お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
515320

世界における組織学・細胞学市場の規模、シェア、動向分析

Histology And Cytology Market Size, Share & Trends Analysis Report By End Use, By Product (Instruments & Analysis Software System, Consumables & Reagents), By Type of Examination, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 160 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
世界における組織学・細胞学市場の規模、シェア、動向分析
出版日: 2020年02月13日
発行: Grand View Research, Inc.
ページ情報: 英文 160 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の組織学・細胞学市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場直線見通し
  • 市場セグメンテーションと範囲
  • 法規制と償還枠組み
  • 市場動向
    • 市場促進因子分析
    • 市場阻害因子分析
  • 浸透度と成長見通しマッピング
  • PESTLE分析
  • 業界分析
  • 主な取引と戦略的分析
  • 市場参入戦略

第4章 診察タイプ別市場予測と動向分析

  • 動向分析
  • 組織学
  • 細胞学
    • 子宮頸癌
    • 乳癌
    • その他の癌

第5章 地域別予測と動向分析

  • 主要企業リスト:地域別
  • SWOT分析
  • 市場シェア
  • 市場規模と予測、動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合環境

  • 戦略枠組み
  • 戦略マッピング
  • 民間企業リスト
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 Number of worldwide cancer deaths, 2018
  • TABLE 2 Regulatory authorities involved in pathology industry: U.K.
  • TABLE 3 Modifications in the cytology CPT codes 2018 vs 2017
  • TABLE 4 List of research institutes
  • TABLE 5 CPT code and description
  • TABLE 6 CPT code and description
  • TABLE 7 List of market players, by region
  • TABLE 8 North America histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 9 North America histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 10 North America histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 11 North America histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 12 U.S. histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 13 U.S. histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 14 U.S. histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 15 U.S. histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 16 Canada histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 17 Canada histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 18 Canada histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 19 Canada histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 20 Europe histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 21 Europe histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 22 Europe histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 23 Europe histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 24 Germany histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 25 Germany histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 26 Germany histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 27 Germany histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 28 U.K. histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 29 U.K. histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 30 U.K. histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 31 U.K. histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 32 France histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 33 France histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 34 France histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 35 France histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 36 Italy histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 37 Italy histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 38 Italy histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 39 Italy histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 40 Spain histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 41 Spain histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 42 Spain histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 43 Spain histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 44 Five most common cancer in men and women in different regions of Asia
  • TABLE 45 Asia Pacific histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 46 Asia Pacific histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 47 Asia Pacific histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 48 Asia Pacific histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 49 China histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 50 China histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 51 China histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 52 China histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 53 Japan histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 54 Japan histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 55 Japan histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 56 Japan histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 57 Latin America histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 58 Latin America histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 59 Latin America histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 60 Latin America histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 61 Brazil histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 62 Brazil histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 63 Brazil histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 64 Brazil histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 65 Mexico histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 66 Mexico histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 67 Mexico histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 68 Mexico histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 69 MEA histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 70 MEA histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 71 MEA histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 72 MEA histology and cytology market, by end use, 2016 - 2027 (USD Million)
  • TABLE 73 South Africa histology and cytology market, by type of examination, 2016 - 2027 (USD Million)
  • TABLE 74 South Africa histology and cytology market, by cytology application, 2016 - 2027 (USD Million)
  • TABLE 75 South Africa histology and cytology market, by product, 2016 - 2027 (USD Million)
  • TABLE 76 South Africa histology and cytology market, by end use, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Global cancer incidence, as of September 2018
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping for products, 2018
  • FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Histology and cytology market: Type of examination type outlook key takeaways
  • FIG. 17 Histology and cytology market: Type of examination market movement analysis
  • FIG. 18 Global histology market, 2016 - 2027 (USD Million)
  • FIG. 19 Global cytology market, 2016 - 2027 (USD Million)
  • FIG. 20 Global cervical cancer cytology market, 2016 - 2027 (USD Million)
  • FIG. 21 Global breast cancer cytology market, 2016 - 2027 (USD Million)
  • FIG. 22 Global other cancer cytology market, 2016 - 2027 (USD Million)
  • FIG. 23 Histology and cytology market: Product outlook key takeaways
  • FIG. 24 Histology and cytology market: Product market movement analysis
  • FIG. 25 Global histology and cytology instruments & analysis software system market, 2016 - 2027 (USD Million)
  • FIG. 26 Global histology and cytology consumable & reagents market, 2016 - 2027 (USD Million)
  • FIG. 27 Histology and cytology market: End-use outlook key takeaways
  • FIG. 28 Histology and cytology market: End-use market movement analysis
  • FIG. 29 Global life science histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 30 Global histology and cytology clinical diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 31 Regional market place: Key takeaways
  • FIG. 32 Histology and cytology market by region: Regional movement analysis
  • FIG. 33 SWOT Analysis - Developed Regions (North America & Europe)
  • FIG. 34 SWOT Analysis-Developing Regions (Asia Pacific, Latin America & MEA)
  • FIG. 35 North America histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 36 U.S. histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 37 Canada histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 38 Europe histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 39 Germany histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 40 U.K. histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 41 France histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 42 Italy histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 43 Spain histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 44 Asia Pacific histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 45 China histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 46 Japan histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 47 Latin America histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 48 Brazil histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 49 Mexico histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 50 MEA histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 51 South Africa histology and cytology market, 2016 - 2027 (USD Million)
  • FIG. 52 Strategy framework
目次
Product Code: GVR-1-68038-917-3

The global histology and cytology market size is expected to reach USD 34.5 billion by 2027 growing at a CAGR of 13.6%, according to a new report by Grand View Research, Inc. Significance for cell-based models in phenotypic assays has increased over the years, mainly targeted towards discovering new disease causative factors while performing an in-depth analysis of disease mechanism and detecting biomarkers with clinical significance. This has fueled the demand for cytological profiling as well as histopathology techniques contributing to the overall growth.

Histology involves microscopic examination of whole tissue samples whereas, cytology includes individualized cellular analysis targeted towards particular disease condition. Cytology is frequently utilized to perform a primary screening of the diseases, based on which the pathologists perform further diagnosis of the patient.

Emerging immunohistochemistry techniques along with the advancements across histology products such as enclosed tissue processors, cryostats, disposable knives, and plastic cassettes is expected to propel market growth. Splurging demand for in-vitro diagnostics is expected to propel the demand for histology among the laboratory professionals.

Further key findings from the study suggest:

  • Cytology accounted for the highest revenue generated in 2019 and is anticipated to maintain this trend throughout the forecast period
  • Cervical cancer is the major contributor to the revenue generated in the cytology segment and is anticipated to witness a CAGR of 11.9% from 2020 to 2027
  • Consumable and reagents have dominated the global histology & cytology market attributed to their large-scale adoption across various protocols right from tissue acquisition to processing or treatment
  • The life sciences end-use segment is set grow at a fastest pace registering a CAGR of 13.9% attributed to increasing employment of digital histology and cytology instruments across oncology and toxicology studies
  • North America accounted for the largest revenue share in 2019 owing to sufficient presence of skilled professionals required to maintain the efficacy of these tests
  • Asia Pacific is expected to offer lucrative opportunities for market expansion, attributed to rising focus on the development of advanced diagnostic techniques
  • International players looking to invest in developing economies of this region have significantly contributed to the projected revenue in this region
  • Some of the key market participants are Abbott, Hologic, Inc.; F. Hoffmann-La Roche Ltd; Becton, Dickinson and Company (BD)
  • In the recent years, the market has witnessed pivotal collaborations amongst the participants for the launch of unique solutions

For instance, in December 2019, F. Hoffmann-La Roche Ltd collaborated with Fortelinea Software Systems targeted towards co-marketing of software solutions in U.S. This was aimed at enhancing workflow across histology research laboratories in the country.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Information procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation

Chapter 2 Executive Summary

Chapter 3 Histology & Cytology Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Rising incidence of cancer
      • 3.1.1.2 Technological developments
      • 3.1.1.3 Increase in awareness programs for cervical cancer screening
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Low sensitivity of cytology tests
      • 3.1.2.2 Conditions required for specimens and problem of mislabeled specimens
  • 3.2 Penetration & Growth Prospect Mapping for Products, 2019
  • 3.3 Histology and cytology Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's
  • 3.5 Regulatory Framework
    • 3.5.1 U.K.
    • 3.5.2 U.S.
  • 3.6 Reimbursement Scenario
  • 3.7 Research Institutes: Histology and Cytology Market

Chapter 4 Histology and Cytology Market: Type of Examination Estimates & Trend Analysis

  • 4.1 Histology and Cytology Market: Type of Examination Movement Analysis
  • 4.2 Histology
    • 4.2.1 Histology market, 2016 - 2027 (USD Million)
  • 4.3 Cytology
    • 4.3.1 Cytology market, 2016 - 2027 (USD Million)
    • 4.3.2 Cervical cancer
      • 4.3.2.1 Cervical cancer cytology market, 2016 - 2027 (USD Million)
    • 4.3.3 Breast cancer
      • 4.3.3.1 Breast cancer cytology market, 2016 - 2027 (USD Million)
    • 4.3.4 Other cancers
      • 4.3.4.1 Pancreatic cancer
      • 4.3.4.2 Bile duct
      • 4.3.4.3 Bladder cancer
      • 4.3.4.4 Other cancers cytology market, 2016 - 2027 (USD Million)

Chapter 5 Histology and Cytology Market: Product Estimates & Trend Analysis

  • 5.1 Histology and Cytology Market: Product Movement Analysis
  • 5.2 Instruments and Analysis Software System
    • 5.2.1 Histology and cytology instruments & analysis software system market, 2016 - 2027 (USD Million)
  • 5.3 Consumable and Reagents
    • 5.3.1 Histology and cytology consumable & reagents market, 2016 - 2027 (USD Million)

Chapter 6 Histology and Cytology Market: End-use Estimates & Trend Analysis

  • 6.1 Histology and Cytology Market: End-use Movement Analysis
  • 6.2 Life Sciences
    • 6.2.1 Life science histology and cytology market, 2016 - 2027 (USD Million)
  • 6.3 Clinical Diagnostics
    • 6.3.1 Histology and cytology clinical diagnostics market, 2016 - 2027 (USD Million)

Chapter 7 Histology and cytology: Regional Estimates & Trend Analysis, by Type of Examination, Product, & End-use

  • 7.1 Histology and cytology Market share by region, 2018 & 2026
  • 7.2 Market Players, by Region
  • 7.3 SWOT Analysis, by Region
  • 7.4 North America
    • 7.4.1 North America histology and cytology market, 2016 - 2027 (USD Million)
    • 7.4.2 U.S.
      • 7.4.2.1 U.S. histology and cytology market, 2016 - 2027 (USD Million)
    • 7.4.3 Canada
      • 7.4.3.1 Canada histology and cytology market, 2016 - 2027 (USD Million)
  • 7.5 Europe
    • 7.5.1 Europe histology and cytology market, 2016 - 2027 (USD Million)
    • 7.5.2 Germany
      • 7.5.2.1 Germany histology and cytology market, 2016 - 2027 (USD Million)
    • 7.5.3 U.K.
      • 7.5.3.1 U.K. histology and cytology market, 2016 - 2027 (USD Million)
    • 7.5.4 France
      • 7.5.4.1 France histology and cytology market, 2016 - 2027 (USD Million)
    • 7.5.5 Italy
      • 7.5.5.1 Italy histology and cytology market, 2016 - 2027 (USD Million)
    • 7.5.6 Spain
      • 7.5.6.1 Spain histology and cytology market, 2016 - 2027 (USD Million)
  • 7.6 Asia Pacific
    • 7.6.1 Asia Pacific histology and cytology market, 2016 - 2027 (USD Million)
    • 7.6.2 China
      • 7.6.2.1 China histology and cytology market, 2016 - 2027 (USD Million)
    • 7.6.3 Japan
      • 7.6.3.1 Japan histology and cytology market, 2016 - 2027 (USD Million)
  • 7.7 Latin America
    • 7.7.1 Latin America histology and cytology market, 2016 - 2027 (USD Million)
    • 7.7.2 Brazil
      • 7.7.2.1 Brazil histology and cytology market, 2016 - 2027 (USD Million)
    • 7.7.3 Mexico
      • 7.7.3.1 Mexico histology and cytology market, 2016 - 2027 (USD Million)
  • 7.8 Middle East and Africa (MEA)
    • 7.8.1 MEA histology and cytology market, 2016 - 2027 (USD Million)
    • 7.8.2 South Africa
      • 7.8.2.1 South Africa histology and cytology market, 2016 - 2027 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Company Profiles
    • 8.2.1 Hologic, Inc.
      • 8.2.1.1 Company overview
      • 8.2.1.2 Financial performance
      • 8.2.1.3 Product benchmarking
      • 8.2.1.4 Strategic initiatives
    • 8.2.2 F. Hoffmann-La Roche Ltd.
      • 8.2.2.1 Company overview
      • 8.2.2.2 Financial performance
      • 8.2.2.3 Product benchmarking
      • 8.2.2.4 Strategic initiatives
    • 8.2.3 Abbott
      • 8.2.3.1 Company overview
      • 8.2.3.2 Financial performance
      • 8.2.3.3 Product benchmarking
    • 8.2.4 Becton, Dickinson & Company
      • 8.2.4.1 Company overview
      • 8.2.4.2 Financial performance
      • 8.2.4.3 Product benchmarking
      • 8.2.4.4 Strategic initiatives
    • 8.2.5 Danaher
      • 8.2.5.1 Company overview
      • 8.2.5.2 Financial performance
      • 8.2.5.3 Product benchmarking
      • 8.2.5.4 Strategic initiatives
    • 8.2.6 Merck KGaA
      • 8.2.6.1 Company overview
      • 8.2.6.2 Financial performance
      • 8.2.6.3 Product benchmarking
      • 8.2.6.4 Strategic initiatives
    • 8.2.7 Thermo Fisher Scientific, Inc.
      • 8.2.7.1 Company overview
      • 8.2.7.2 Financial performance
      • 8.2.7.3 Product benchmarking
      • 8.2.7.4 Strategic initiatives
    • 8.2.8 Sysmex Corporation
      • 8.2.8.1 Company overview
      • 8.2.8.2 Financial performance
      • 8.2.8.3 Product benchmarking
      • 8.2.8.4 Strategic initiatives
    • 8.2.9 Trivitron Healthcare
      • 8.2.9.1 Company overview
      • 8.2.9.2 Financial performance
      • 8.2.9.3 Product benchmarking
      • 8.2.9.4 Strategic initiatives
    • 8.2.10 Koninklijke Philips N.V.
      • 8.2.10.1 Company overview
      • 8.2.10.2 Financial performance
      • 8.2.10.3 Product benchmarking
      • 8.2.10.4 Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.